USE OF PROBIOTICS IN THE TREATMENT OF PATIENTS WITH IBS – (01-09-06)

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome a double blind, placebo-controlled, randomized study

This is the kind of poorly thought out study that ends up confusing patients. This study found no benefit in 6 months’ use of probiotics at 200 million CFU per day.

Consider that studies in infants on effecting rotavirus use 2-3 BILLION per day, the idea of using 200 million and not seeing a significant effect would be no big shocker. The problem is that physicians who do not know any better will look to studies like this and say, “See-I told you this stuff isn’t effective.”

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: